Analyst	Recommendation	Action	Price target	Projected	Date
Maria Meita Bernstein	Buy	Initiated	$12.90	+29%	10/07/2026
Oliver Chen TD Cowen	Buy	Maintained	$11.00	+10%	09/24/2026
Matthew Boss J.P. Morgan	Hold	Reiterated	$10.00	0%	09/17/2026
Anna Glaessgen B. Riley Securities	Buy	Maintained	$13.00	+30%	09/17/2026
Grace Smalley Morgan Stanley	Hold	Maintained	$9.60	-4%	02/17/2026

All values in EUR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	573.50M	646.92M	618.47M	663.80M
Cost of goods sold	322.76M	338.34M	337.14M	344.21M
Cost of revenue	322.76M	338.34M	337.14M	344.21M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	267.82M	298.11M	287.16M	312.94M
Operating expense	291.60M	312.71M	300.27M	326.44M
Total operating expenses	614.36M	651.05M	637.41M	670.65M
Operating income	-40.86M	-4.13M	-18.94M	-6.84M
Other non operating income	1.00K	-1.00K	-	1.00K
EBT including unusual items	-82.76M	-12.29M	-29.77M	-32.60M
EBT excluding unusual items	-41.97M	-2.21M	-23.39M	-9.50M
Income tax expense	2.57M	358.00K	1.42M	-7.10M
Effective tax rate	-3.10%	-2.91%	-4.79%	21.79%
Other operating expenses	12.17M	2.25M	-5.63M	6.03M
Net income	-98.50M	-7.44M	-35.41M	-26.34M
Net profit margin	-17.18%	-1.15%	-5.73%	-3.97%
Earnings per share	-0.29	0.04	-0.11	0.00
Interest and investment income	1.95M	1.42M	3.37M	1.01M
Interest expense	-3.06M	-3.28M	-3.41M	-4.28M
Net interest expenses	-1.10M	-1.87M	-41.00K	-3.27M
Depreciation and amortization charges	11.61M	12.35M	18.74M	7.48M
EBITDA	-29.26M	8.12M	-8.03M	-1.55M
Gain or loss from assets sale	-	-	-	-

Ask anything